Trulicity 1.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FA3BZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,029
Award facts
- Contract value 100% obligated
- $32,029.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,029.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen auto-injectors on August 28, 2025. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999.99 million through December 2026), will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication used to improve blood sugar control in patients with type 2 diabetes, reflecting the pharmaceutical distributor's role in supplying critical medications to support military and federal healthcare systems.
This non-set-aside award was competitively procured and demonstrates AmerisourceBergen's established capability to meet federal medical procurement requirements through the DLA's pharmaceutical supply chain. As a major healthcare solutions provider and pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contracts for medical products spanning multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. The award is part of the company's ongoing support to the Defense Health Agency and other federal healthcare beneficiaries through flexible contract vehicles designed to ensure reliable access to essential pharmaceutical commodities across military medical facilities worldwide.
Quick answers
Who was awarded contract SPE2DB25FA3BZ?
SPE2DB25FA3BZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FA3BZ worth?
The government has obligated $32,029 on SPE2DB25FA3BZ.
Is contract SPE2DB25FA3BZ an order under another contract?
Yes. SPE2DB25FA3BZ is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FA3BZ competed?
The extent of competition for SPE2DB25FA3BZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award